NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 of SEBI (LODR) Regulations, 201516-02-2021
16-02-2021
NEULAND LABORATORIES LTD. - 524558 - Clarification On Price Movement
Clarification on Price Movement11-02-2021
NEULAND LABORATORIES LTD. - 524558 - Clarification sought from Neuland Laboratories Ltd
The Exchange has sought clarification from Neuland Laboratories Ltd on February 11, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.11-02-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith copies of the newspaper publication of Un-audited Financial Results for the quarter ended December 31, 2020, published in Financial Express and Andhra Prabha on February 3, 2021 for your reference.03-02-2021
Earnings Call for Q3FY21 of Neuland Laboratories
Conference Call with Neuland Laboratories Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.03-02-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation02-02-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release02-02-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release02-02-2021
NEULAND LABORATORIES LTD. - 524558 - Unaudited Standalone & Consolidated Financial Results For Q3 And 9M FY 2020-21
Unaudited Standalone & Consolidated Financial Results for Q3 and 9M FY 2020-2102-02-2021